hims hers compounded semaglutide Novo Nordisk calls out dangers of GLP-1s in new ad FDA Blocks Hims & Hers
Description
Last Updated: April 29, 2026
Real medical supervision Every program is prescribed and monitored by licensed providers, not a vending-machine app
Introduce the Water to the Peptide: This is the most delicate step
A bunch of people in the GLP-1 groups said the same thing
Participants in the retatrutide group experienced more gastrointestinal symptoms such as nausea and diarrhoea, which are common side effects of GLP-1 receptor agonists
Volkow ND, Xu R
